Stock brokerages have recently come out with research reports on select stocks namely Dabur India, Star Health, Motilal Oswal and Carysil. Shares such as Star Health, Motilal Oswal and Carysil have received 'Buy' recommendations, while Dabur India has received 'Accumulate' tag. Analyst targets on these stocks suggest up to 45% potential upside over the next 12 months.
Brokerage firm ICICI Securities has maintained its 'Buy'rating on Motilal Oswal Financial Services with a target price of Rs 900 apiece, as it finds the valuations of the company attractive.
Motilal Oswal’s efforts towards improving its broking volume share and AMC performance, increasing wealth management AUM through expanding RM pool, and growing HFC portfolio sustainably and profitably, could potentially provide tailwinds to earnings, said ICICI Securities.
Prabhudas Lilladhar has an 'Accumulate' rating on Dabur India with a target price of Rs 609, as it values the FMCG stock at 38.3 times on FY25 EPS.
Domestic demand is showing signs of recovery for Dabur India, but untimely rains and changing weather patterns may delay rural recovery. Broader margins have bottomed out, but delayed recovery can result in back-ended returns, said Prabhudas Lilladher.
The Gujarat-based brokerage firm Monarch Capital has initiated coverage on Carysil with a target price of Rs 780, suggesting an upside of 30% from the current levels.
Monarch estimates Carysil has a market share of more than 20% in quartz sinks globally. Its vast global presence will be further fortified by the company’s widened product portfolio through the addition of adjacent categories such as steel sinks, kitchen appliances, countertops, and bathroom fittings.
ICICI Securities has maintained its 'Buy' call on Star Health and Allied Insurance Company with a revised target price of Rs 800 from Rs 730 earlier.
ICICI Securities factored in a premium-income CAGR of 22% over FY23-FY25, a combined ratio of 95% and an investment yield of 7.5% each year for FY23E and FY24E. Risks include spike in claims, as was seen during covid and possible increase in competitive intensity due to introduction of composite license.
Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Business Today. Investors should consult their financial advisors before taking any position.